- Novozymes A/S 2024 Outlook and 2023 Pro Forma Financials Call TranscriptMar 21, 2024
- Novozymes A/S Extraordinary Shareholders Meeting TranscriptMar 04, 2024
- Q4 2023 Novozymes A/S Earnings Call TranscriptFeb 01, 2024kr371.6 (+4.88%)Earnings
- Q3 2023 Novozymes A/S Earnings Call TranscriptOct 26, 2023kr299.9 (+7.96%)Earnings
- Q2 2023 Novozymes A/S Earnings Call TranscriptAug 09, 2023kr327.7Earnings
- Q1 2023 Novozymes A/S Earnings Call TranscriptApr 26, 2023kr355.2 (-3.53%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 02, 2023
- Q4 2022 Novozymes A/S Earnings Call TranscriptJan 26, 2023kr348.3 (-0.68%)Earnings
- Novozymes A/S and Chr Hansen Holding A/S to Discuss Agreement to Combine Through a Statutory Merger Call TranscriptDec 12, 2022
- Q3 2022 Novozymes A/S Earnings Call TranscriptNov 03, 2022kr395 (+1.28%)Earnings
- Q2 2022 Novozymes A/S Earnings Call TranscriptAug 11, 2022kr452.5 (+3.00%)Earnings
- Novozymes A/S Spotlight on Human Health Presentation TranscriptJun 17, 2022
- Q1 2022 Novozymes A/S Earnings Call TranscriptApr 27, 2022kr483.2 (+2.83%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 16, 2022
- Q4 2021 Novozymes A/S Earnings Call TranscriptFeb 01, 2022kr441 (-2.63%)Earnings
- Q3 2021 Novozymes A/S Earnings Call TranscriptOct 27, 2021kr472 (+0.62%)Earnings
- Novozymes A/S Capital Markets Day (Virtual) TranscriptSep 28, 2021
- Q2 2021 Novozymes A/S Earnings and to Discuss Investment Into Advanced Protein Solutions Call TranscriptAug 12, 2021
- Q1 2021 Novozymes A/S Earnings Call TranscriptApr 27, 2021kr444.7 (+5.58%)Earnings
- Novozymes A/S Annual Shareholders Meeting TranscriptMar 11, 2021
- Q4 2020 Novozymes A/S Earnings Call TranscriptFeb 02, 2021kr373.4 (-0.69%)Earnings
- Q3 2020 Novozymes A/S Earnings Call TranscriptOct 21, 2020kr392.5 (-5.38%)Earnings
- Q2 2020 Novozymes A/S Earnings Call TranscriptAug 12, 2020kr368.9 (-3.76%)Earnings
- Q2 2020 Novozymes A/S Trading Update Call TranscriptJul 08, 2020
- Q1 2020 Novozymes A/S Earnings Call TranscriptApr 29, 2020kr326.2 (+2.35%)Earnings
- Q1 2020 Novozymes A/S Organic Sales Call TranscriptApr 07, 2020
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 26, 2020
- Q4 2019 Novozymes A/S Earnings Call TranscriptJan 23, 2020kr351.4 (+6.65%)Earnings
- Q3 2019 Novozymes A/S Earnings Call TranscriptOct 23, 2019kr304.3 (+4.93%)Earnings
- Novozymes A/S to Discuss the Adjusted FY 2019 Outlook Call TranscriptOct 10, 2019
- Q2 2019 Novozymes A/S Earnings Call TranscriptAug 08, 2019kr288.8 (-4.31%)Earnings
- Novozymes A/S Capital Markets Day 2019 TranscriptJun 17, 2019
- Q1 2019 Novozymes A/S Earnings Call TranscriptApr 24, 2019kr309 (-2.49%)Earnings
- Novozymes A/S to Discuss the Continuation of Partnership with Bayer AG and with Two New Partners, Univar Solutions and UPL Ltd Call TranscriptApr 05, 2019
- Novozymes A/S Annual Shareholders Meeting TranscriptFeb 27, 2019
Q3 2019 Novozymes A/S Earnings Call Transcript
/-&
Good morning, and welcome to the Novozymes conference call. Today, we'll review our performance for the first 9 months of 2019 as well as our outlook and our current priorities. As we hosted the conference call on October 10 following the updated full year outlook, today's presentation will be shorter and should take no more than about 15 minutes. Afterwards, we'll be happy to take your questions.
My name is Peder Holk Nielsen, and I'm the CEO of Novozymes. I'm joined here today by the Executive Leadership Team and Investor Relations.
Before we jump into the subject matter, I would like to take this opportunity to properly welcome Lars Green to the Executive Leadership Team. He has held various financial positions at Novo Nordisk both in Denmark and abroad and has since 2017 been a member of the Novo Nordisk executive management team. Lars knows Novozymes very well as he has been on the Board and been the Chairman of the Audit Committee since 2014. I think he's the perfect match for us
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)